16th Mar 2021 7:00 am |
RNS |
US supply agreement for additional AZD7442 doses |
9th Mar 2021 3:00 pm |
RNS |
Director/PDMR Shareholding |
4th Mar 2021 3:00 pm |
RNS |
Designation of EU home member state |
3rd Mar 2021 7:00 am |
RNS |
US court decision favours Symbicort patents |
2nd Mar 2021 7:00 am |
RNS |
Further update on roxadustat US regulatory review |
1st Mar 2021 3:00 pm |
RNS |
Total Voting Rights |
22nd Feb 2021 7:00 am |
RNS |
Voluntary withdrawal Imfinzi US bladder indication |
17th Feb 2021 7:00 am |
RNS |
Lynparza: IDMC recommend early analysis of OlympiA |
16th Feb 2021 11:15 am |
RNS |
Filing of Form 20-F with SEC |
15th Feb 2021 3:00 pm |
RNS |
Director/PDMR Shareholding |
15th Feb 2021 11:00 am |
RNS |
Annual Financial Report |
11th Feb 2021 7:01 am |
RNS |
AstraZeneca Non-Executive Board changes |
11th Feb 2021 7:00 am |
RNS |
AZN: full-year 2020 results |
10th Feb 2021 7:00 am |
RNS |
Divestment of Crestor in Europe completed |
5th Feb 2021 7:00 am |
RNS |
Update on KESTREL Phase III trial for Imfinzi |
4th Feb 2021 7:00 am |
RNS |
Forxiga approved in China for heart failure |
1st Feb 2021 3:00 pm |
RNS |
Total Voting Rights |
1st Feb 2021 12:15 pm |
RNS |
AstraZeneca agrees to divest Viela shareholding |
1st Feb 2021 7:00 am |
RNS |
COVID-19 vaccine authorised for use by the EU |
29th Jan 2021 3:16 pm |
RNS |
COVID-19 vaccine receives positive opinion in EU |
26th Jan 2021 3:00 pm |
RNS |
Block listing application |
26th Jan 2021 7:00 am |
RNS |
Symbicort approved in China for mild asthma |
25th Jan 2021 7:05 am |
RNS |
Calquence approved in Japan for CLL |
25th Jan 2021 7:00 am |
RNS |
Calquence met primary endpoint against ibrutinib |
20th Jan 2021 7:00 am |
RNS |
Enhertu approved in the EU for breast cancer |
18th Jan 2021 7:00 am |
RNS |
Enhertu approved in the US for gastric cancer |
15th Jan 2021 7:00 am |
RNS |
Imfinzi new dosing approved in EU |
6th Jan 2021 7:00 am |
RNS |
Farxiga granted US Priority Review for CKD |
4th Jan 2021 3:00 pm |
RNS |
Total Voting Rights |
4th Jan 2021 7:00 am |
RNS |
Atacand divestment in over 70 countries completed |
30th Dec 2020 7:00 am |
RNS |
AstraZeneca’s COVID-19 vaccine authorised in UK |
29th Dec 2020 7:00 am |
RNS |
Lynparza approved in Japan for three cancers |
21st Dec 2020 7:05 am |
RNS |
Tagrisso approved in the US for early lung cancer |
21st Dec 2020 7:00 am |
RNS |
Update on US regulatory review of roxadustat |
17th Dec 2020 4:00 pm |
RNS |
Director/PDMR Shareholding |
16th Dec 2020 6:15 pm |
RNS |
Director/PDMR Shareholding |
15th Dec 2020 7:00 am |
RNS |
Imfinzi new dose receives positive EU CHMP opinion |
14th Dec 2020 7:05 am |
RNS |
Trastuzumab deruxtecan positive CHMP |
14th Dec 2020 7:00 am |
RNS |
Trixeo Aerosphere approved in the EU for COPD |
14th Dec 2020 7:00 am |
RNS |
AstraZeneca to acquire Alexion Pharmaceuticals Inc |